Related Experiment Videos
Bladder cancer in women
1Head, Urology Section, Rabin Medical Center, Beilinson Campus, Petach Tikva, Israel.
International Urogynecology Journal and Pelvic Floor Dysfunction
|December 30, 1999
Summary
Bladder cancer in women over 60 presents with hematuria and is staged as superficial or invasive. Management varies by stage, with superficial disease having good survival and invasive disease requiring extensive surgery.
Area of Science:
- Urology
- Oncology
Background:
- Bladder cancer constitutes 3% of female cancers, typically affecting women over 60.
- Hematuria is the primary symptom, necessitating radiological imaging and cystoscopy for diagnosis.
Purpose of the Study:
- To outline the characteristics, prognosis, and management strategies for bladder cancer in women.
- To differentiate between superficial and invasive bladder cancer and their respective treatment approaches.
Main Methods:
- Review of prognostic indicators, focusing on tumor grade and stage.
- Description of management for superficial bladder cancer: transurethral resection and intravesical therapy.
- Outline of treatment for invasive bladder cancer: radical surgery, chemotherapy, and radiotherapy.
Main Results:
- Superficial bladder cancer (70-80% of cases) generally has good survival and acceptable morbidity.
- Invasive bladder cancer (20% of cases) has a poorer prognosis with a 5-year survival rate around 50%.
Conclusions:
- Early detection and accurate staging are crucial for effective bladder cancer management in women.
- Treatment strategies must be tailored to disease stage, balancing surgical intervention with adjuvant therapies for optimal outcomes.